These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 6702507)

  • 1. Antiplatelet drugs and thrombosis prevention: ticlopidine in perspective.
    de Gaetano G; Bertelé V
    Agents Actions; 1984 Jan; 14(1):109-12. PubMed ID: 6702507
    [No Abstract]   [Full Text] [Related]  

  • 2. Ex vivo and in vivo evaluation of drugs that inhibit platelet function.
    Hanson SR; Harker LA
    Ann N Y Acad Sci; 1983; 416():642-50. PubMed ID: 6587821
    [No Abstract]   [Full Text] [Related]  

  • 3. The in vivo pharmacological profile of CS-747, a novel antiplatelet agent with platelet ADP receptor antagonist properties.
    Sugidachi A; Asai F; Ogawa T; Inoue T; Koike H
    Br J Pharmacol; 2000 Apr; 129(7):1439-46. PubMed ID: 10742300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antithrombotic effect of ticlopidine in a platelet-independent model of venous thrombosis.
    Bernat A; Vallée E; Maffrand JP; Roncucci R
    Thromb Res; 1985 Jan; 37(2):279-85. PubMed ID: 3975872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ticlopidine hydrochloride: relationship between dose, kinetics, plasma concentration and effect on platelet function.
    Picard-Fraire C
    Thromb Res Suppl; 1983; 4():119-28. PubMed ID: 6356462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiplatelet drugs and thrombosis prevention: ticlopidine in perspective.
    de Gaetano G; Bertelé V
    Arq Bras Cardiol; 1983 Dec; 41(6):425-7. PubMed ID: 6678584
    [No Abstract]   [Full Text] [Related]  

  • 7. The mechanisms of action of ticlopidine.
    Bruno JJ
    Thromb Res Suppl; 1983; 4():59-67. PubMed ID: 6356466
    [No Abstract]   [Full Text] [Related]  

  • 8. The effect of ticlopidine on platelet function in normal volunteers and in patients with platelet hyperaggregability in vitro.
    Knudsen JB; Gormsen J
    Thromb Res; 1979; 16(5-6):663-71. PubMed ID: 524316
    [No Abstract]   [Full Text] [Related]  

  • 9. Ticlopidine: a promise for the prevention and treatment of thrombosis and its complications.
    Panak E; Maffrand JP; Picard-Fraire C; Vallée E; Blanchard J; Roncucci R
    Haemostasis; 1983; 13 Suppl 1():1-54. PubMed ID: 6642292
    [No Abstract]   [Full Text] [Related]  

  • 10. Ticlopidine - an antiplatelet drug: effects in human volunteers.
    O'Brien JR; Etherington MD; Shuttleworth RD
    Thromb Res; 1978 Aug; 13(2):245-54. PubMed ID: 694843
    [No Abstract]   [Full Text] [Related]  

  • 11. The antiaggregating and antithrombotic activity of ticlopidine is potentiated by aspirin in the rat.
    Herbert JM; Bernat A; Samama M; Maffrand JP
    Thromb Haemost; 1996 Jul; 76(1):94-8. PubMed ID: 8819259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenosine diphosphate (ADP)-induced alpha-granules release from platelets of native whole blood is reduced by ticlopidine but not by aspirin or dipyridamole.
    Pengo V; Boschello M; Marzari A; Baca M; Schivazappa L; Dalla Volta S
    Thromb Haemost; 1986 Oct; 56(2):147-50. PubMed ID: 3810554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet activation induced by a human neuroblastoma tumor cell line is reduced by prior administration of ticlopidine.
    Bastida E; Escolar G; Almirall L; Ordinas A
    Thromb Haemost; 1986 Jun; 55(3):333-7. PubMed ID: 3750263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet aggregation measured in rabbit whole blood: in vitro study of 3 aggregating agents and ex vivo inhibition by aspirin and ticlopidine.
    Chevolet C; Grosdent JC; Reiters GM; Dresse A
    Arch Int Pharmacodyn Ther; 1982 Oct; 259(2):310-1. PubMed ID: 6817725
    [No Abstract]   [Full Text] [Related]  

  • 15. [Experimental platelet aggregation and arterial thrombosis. Effect of aspirin].
    Bousser MG; Lecrubier C
    Nouv Presse Med; 1973 Jun; 2(25):1687-92. PubMed ID: 4718537
    [No Abstract]   [Full Text] [Related]  

  • 16. Antiplatelet drugs in the management of patients with thrombotic disorders.
    Harker LA
    Semin Thromb Hemost; 1986 Apr; 12(2):134-55. PubMed ID: 3016905
    [No Abstract]   [Full Text] [Related]  

  • 17. Interaction of platelets with subendothelium in rats treated with PCA-4230, a new antithrombotic agent. Effect of PCA-4230 on experimental thrombosis.
    Gutiérrez Díaz JA; Tolón RM; Sunkel C; Priego JG; Ortega MP
    Haemostasis; 1992; 22(4):202-10. PubMed ID: 1468723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular identification and characterization of the platelet ADP receptor targeted by thienopyridine antithrombotic drugs.
    Foster CJ; Prosser DM; Agans JM; Zhai Y; Smith MD; Lachowicz JE; Zhang FL; Gustafson E; Monsma FJ; Wiekowski MT; Abbondanzo SJ; Cook DN; Bayne ML; Lira SA; Chintala MS
    J Clin Invest; 2001 Jun; 107(12):1591-8. PubMed ID: 11413167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clopidogrel versus prasugrel in rabbits. Effects on thrombosis, haemostasis, platelet function and response variability.
    Wong PC; Crain EJ; Watson CA; Hua J; Schumacher WA; Rehfuss R
    Thromb Haemost; 2009 Jan; 101(1):108-15. PubMed ID: 19132196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of the inhibitory action of prostaglandin E1 on platelet aggregation in rats: a study with ticlopidine, aspirin, dipyridamole and sulfinpyrazone.
    Tuong CC; Ferrand C; Aubert D; Loubrie JC; Tuong A
    Biochem Pharmacol; 1982 Mar; 31(6):1147-50. PubMed ID: 7200772
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.